Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qianting Yang

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
American Journal of Infection Control|June 3, 2015
Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospitalJiao Xie, Yan Wang, Xiaowei Zheng, et al.
Rapid Communications in Mass Spectrometry : RCM|April 29, 2021
Determination of tigecycline in human lung epithelial cells and polymorphonuclear neutrophils by liquid chromatography/tandem mass spectrometry and its application in a cellular pharmacokinetics studyQianting Yang, Jiao Xie, Haitao Wang, et al.
Open Forum Infectious Diseases|June 30, 2021
Evaluation of a Cryptococcal Antigen Lateral Flow Assay and Cryptococcal Antigen Positivity at a Large Public Hospital in Atlanta, GeorgiaKristin R V Harrington, Yun F Wang, Paulina A Rebolledo, et al.
American Journal of Respiratory and Critical Care Medicine|December 19, 2009
Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T CellsXinchun Chen, Mingxia Zhang, Mingfeng Liao, et al.
International Journal of Antimicrobial Agents|April 13, 2016
Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populationsQianting Yang, Taotao Wang, Jiao Xie, et al.
BMC Pharmacology & Toxicology|November 19, 2025
Revised therapeutic window for vancomycin in pediatric patients: evidence from a retrospective therapeutic drug monitoring studyTao Zhang, Jingjing Yi, Hua Cheng, et al.
Pharmacotherapy|June 11, 2016
Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care UnitYan Wang, Taotao Wang, Jiao Xie, et al.
Plos One|June 22, 2012
Increased levels of BAFF and APRIL related to human active pulmonary tuberculosisKai Liu, Yan Zhang, Shizong Hu, et al.
Analytical Chemistry|April 18, 2024
LectoScape: A Highly Multiplexed Imaging Platform for Glycome Analysis and Biomedical DiagnosisLujie Yang, Qianting Yang, Ling Lin, et al.
Journal of Translational Medicine|June 9, 2018
A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics modelTaotao Wang, Tao Zhang, Ti Meng, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
American Journal of Infection Control|June 3, 2015
Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospitalJiao Xie, Yan Wang, Xiaowei Zheng, et al.
Rapid Communications in Mass Spectrometry : RCM|April 29, 2021
Determination of tigecycline in human lung epithelial cells and polymorphonuclear neutrophils by liquid chromatography/tandem mass spectrometry and its application in a cellular pharmacokinetics studyQianting Yang, Jiao Xie, Haitao Wang, et al.
Open Forum Infectious Diseases|June 30, 2021
Evaluation of a Cryptococcal Antigen Lateral Flow Assay and Cryptococcal Antigen Positivity at a Large Public Hospital in Atlanta, GeorgiaKristin R V Harrington, Yun F Wang, Paulina A Rebolledo, et al.
American Journal of Respiratory and Critical Care Medicine|December 19, 2009
Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T CellsXinchun Chen, Mingxia Zhang, Mingfeng Liao, et al.
International Journal of Antimicrobial Agents|April 13, 2016
Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populationsQianting Yang, Taotao Wang, Jiao Xie, et al.
BMC Pharmacology & Toxicology|November 19, 2025
Revised therapeutic window for vancomycin in pediatric patients: evidence from a retrospective therapeutic drug monitoring studyTao Zhang, Jingjing Yi, Hua Cheng, et al.
Pharmacotherapy|June 11, 2016
Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care UnitYan Wang, Taotao Wang, Jiao Xie, et al.
Plos One|June 22, 2012
Increased levels of BAFF and APRIL related to human active pulmonary tuberculosisKai Liu, Yan Zhang, Shizong Hu, et al.
Analytical Chemistry|April 18, 2024
LectoScape: A Highly Multiplexed Imaging Platform for Glycome Analysis and Biomedical DiagnosisLujie Yang, Qianting Yang, Ling Lin, et al.
Journal of Translational Medicine|June 9, 2018
A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics modelTaotao Wang, Tao Zhang, Ti Meng, et al.
Pageof 9